214759-66-7 Usage
Uses
Used in Pharmaceutical Industry:
METHYL 3-CHLORO-4-CYANOBENZOATE is used as an intermediate for the production of various medicines. Its presence in the synthesis process contributes to the development of new and effective pharmaceuticals, enhancing the range of treatments available for various health conditions.
Used in Agricultural Industry:
In the agricultural sector, METHYL 3-CHLORO-4-CYANOBENZOATE is utilized in the production of pesticides. Its role in the formulation of these agrochemicals helps protect crops from pests and diseases, ensuring a stable and productive agricultural output.
Used in Organic Synthesis:
METHYL 3-CHLORO-4-CYANOBENZOATE is employed as a building block in organic synthesis. Its unique structure allows for the creation of a wide range of organic compounds, expanding the possibilities for chemical innovation and development.
Used in Chemical Research:
As a reagent in chemical research, METHYL 3-CHLORO-4-CYANOBENZOATE is instrumental in advancing scientific understanding and discovery. Its use in various experimental procedures and analyses contributes to the advancement of knowledge in the field of chemistry.
It is crucial to handle METHYL 3-CHLORO-4-CYANOBENZOATE with care, as it may pose health and environmental hazards. Proper safety measures and precautions should be taken during its use to minimize potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 214759-66-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,7,5 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 214759-66:
(8*2)+(7*1)+(6*4)+(5*7)+(4*5)+(3*9)+(2*6)+(1*6)=147
147 % 10 = 7
So 214759-66-7 is a valid CAS Registry Number.
InChI:InChI=1S/C9H6ClNO2/c1-13-9(12)6-2-3-7(5-11)8(10)4-6/h2-4H,1H3
214759-66-7Relevant articles and documents
BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RARβ) AGONISTS
-
Page/Page column 67; 68, (2016/07/05)
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain bicycloheteroaryl-heteroaryl-benzoic acid compounds of the following formula (for convenience, collectively referred to herein as "BHBA compou
HETEROCYCLIC COMPOUND
-
Paragraph 0896, (2016/03/18)
The present invention provides a heterocyclic compound having an RORγt inhibitory action. The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optinally having substituent(s), or a salt thereof.
Farnesyltransferase inhibitors
-
, (2008/06/13)
Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
Farnesyltransferase inhibitors
-
, (2008/06/13)
Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
Substituted phenyl farnesyltransferase inhibitors
-
, (2012/09/25)
Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
